CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices

David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023.CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company's Caremark unit, which are widely accused of inflating prescription medication prices, and instead accused manufacturers of "monopolistic tendencies" that keep drug costs high in the U.S. Joyner, who stepped into the role in October, spent much of his open ...